Deficiency Letter, IDE Review Changes May Be Among MDUFA Gifts to Industry

Devices & Diagnostics Letter
Higher user fees and the FDA’s corresponding pledge to improve performance at CDRH stole the spotlight during the Medical Device User Fee Act (MDUFA) reauthorization process earlier this year.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00